Study of Cingal™ for the Relief of Knee Osteoarthritis Compared to Triamcinolone Hexacetonide

NCT03191903 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

576

Enrollment

INDUSTRY

Sponsor class

Conditions

Knee Osteoarthritis

Interventions

COMBINATION_PRODUCT: Cingal
DEVICE: Monovisc
DRUG: Triamcinolone Hexacetonide

Sponsor

Anika Therapeutics, Inc.